Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2019

01-07-2019 | Original Article

Clinical, radiological, and histological characteristics of Chinese type 2 diabetic patients with diabetic scleredema: an observational study

Authors: Yingying Zhou, Chaoming Wu, Zhijuan Dai, Jian Jin, Yaoxin Zhu, Yanying Qian

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2019

Login to get access

Abstract

Objectives

Diabetic scleredema (DS) is reported rarely in China and its features are poorly documented. We aim to describe the characteristics of Chinese patients with DS clinically, radiologically, and histologically.

Methods

Of 9825 hospitalized participants with diabetes older than 18 years, 15 type 2 diabetes patients with DS as well as 15 non-DS patients with type 2 diabetes were included in this observational study.

Results

All the individuals with DS presented diffuse erythema, non-pitting, and painless indurations on the skin of the nape and upper back. Patients with DS were mainly middle-aged or elderly (male to female ratio, 4:1), with long-standing poorly controlled type 2 diabetes, overweight, or obese. Patients with DS vs non-DS had a higher prevalence of diabetic microvascular complications, neuropathy, hypertension, cerebral infarction, nicotine abuse, and alcohol abuse. LDL-C level was significantly higher in the DS group (p = 0.0143), and the skin and subcutaneous fat in T2-weighted MRI were significantly thickened in the DS group than in the non-DS group (p < 0.01). Skin biopsies showed thickened collagen bundles throughout the dermis and active fibroblast proliferation.

Conclusion

Our reports suggest that DS is relatively rare in Chinese patients with diabetes. DS occurs both in middle-aged and elderly patients (male predominantly), overweight or obese, having long-term poorly controlled type 2 diabetes, and presenting a high incidence of microvascular complications, hypertension, neuropathy, and ischemic cerebral stroke. High LDL-C level, nicotine abuse, and alcohol abuse may be risk factors. MRI could be preferable to assess the severity of DS non-invasively.
Literature
1.
go back to reference Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin N Am. 2013;42:869–98.CrossRef Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin N Am. 2013;42:869–98.CrossRef
3.
go back to reference Cole GW, Headley J, Skowsky R. Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care. 1983;6:189–92.CrossRefPubMed Cole GW, Headley J, Skowsky R. Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care. 1983;6:189–92.CrossRefPubMed
4.
go back to reference Martin C, Requena L, Manrique K, Manzarbeitia FD, Rovira A. Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2011;2011:560273.PubMedPubMedCentral Martin C, Requena L, Manrique K, Manzarbeitia FD, Rovira A. Scleredema diabeticorum in a patient with type 2 diabetes mellitus. Case Rep Endocrinol. 2011;2011:560273.PubMedPubMedCentral
5.
go back to reference Chatterjee S. Neck pain, stiffness, and periorbital edema in a man with diabetes. Jama. 2016;315:1159–60.CrossRefPubMed Chatterjee S. Neck pain, stiffness, and periorbital edema in a man with diabetes. Jama. 2016;315:1159–60.CrossRefPubMed
6.
go back to reference Miyares FJ, Kuriakose R, Deleu DT, El-Wahad NA, Al-Hail H. Scleredema diabeticorum with unusual presentation and fatal outcome. Indian J Dermatol. 2008;53:217–9.CrossRefPubMedPubMedCentral Miyares FJ, Kuriakose R, Deleu DT, El-Wahad NA, Al-Hail H. Scleredema diabeticorum with unusual presentation and fatal outcome. Indian J Dermatol. 2008;53:217–9.CrossRefPubMedPubMedCentral
7.
go back to reference Wilson BE, Newmark JJ. Severe scleredema diabeticorum and insulin resistance. J Am Board Fam Pract. 1995;8:55–7.PubMed Wilson BE, Newmark JJ. Severe scleredema diabeticorum and insulin resistance. J Am Board Fam Pract. 1995;8:55–7.PubMed
8.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–101.CrossRefPubMed
10.
go back to reference Kobayashi T, Yamasaki Y, Watanabe T. Diabetic scleredema: a case report and biochemical analysis for glycosaminoglycans. J Dermatol. 1997;24:100–3.CrossRefPubMed Kobayashi T, Yamasaki Y, Watanabe T. Diabetic scleredema: a case report and biochemical analysis for glycosaminoglycans. J Dermatol. 1997;24:100–3.CrossRefPubMed
11.
go back to reference Nakajima K, Iwagaki M, Ikeda M, Kodama H. Two cases of diabetic scleredema that responded to PUVA therapy. J Dermatol. 2006;33:820–2.CrossRefPubMed Nakajima K, Iwagaki M, Ikeda M, Kodama H. Two cases of diabetic scleredema that responded to PUVA therapy. J Dermatol. 2006;33:820–2.CrossRefPubMed
12.
go back to reference Koga N. Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema. Ther Apher. 2001;5:506–12.CrossRefPubMed Koga N. Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema. Ther Apher. 2001;5:506–12.CrossRefPubMed
13.
go back to reference Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher. 2001;5:244–51.CrossRefPubMed Koga N. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher. 2001;5:244–51.CrossRefPubMed
14.
go back to reference Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–21.CrossRefPubMed Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–21.CrossRefPubMed
15.
go back to reference Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, et al. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol. 2015;29:2399–404.CrossRefPubMed Rongioletti F, Kaiser F, Cinotti E, Metze D, Battistella M, Calzavara-Pinton PG, et al. Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol. 2015;29:2399–404.CrossRefPubMed
16.
go back to reference Sternberg M, Urios P, Grigorova-Borsos AM. Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus. C R Seances Soc Biol Fil. 1995;189:967–85.PubMed Sternberg M, Urios P, Grigorova-Borsos AM. Effects of glycation process on the macromolecular structure of the glomerular basement membranes and on the glomerular functions in aging and diabetes mellitus. C R Seances Soc Biol Fil. 1995;189:967–85.PubMed
17.
go back to reference Chvapil M, Hurych J. Control of collagen biosynthesis. Int Rev Connect Tissue Res. 1968;4:67–196.CrossRefPubMed Chvapil M, Hurych J. Control of collagen biosynthesis. Int Rev Connect Tissue Res. 1968;4:67–196.CrossRefPubMed
18.
go back to reference Ikeda Y, Suehiro T, Abe T, Yoshida T, Shinoki T, Tahara K, et al. Severe diabetic scleredema with extension to the extremities and effective treatment using prostaglandin E1. Intern Med. 1998;37:861–4.CrossRefPubMed Ikeda Y, Suehiro T, Abe T, Yoshida T, Shinoki T, Tahara K, et al. Severe diabetic scleredema with extension to the extremities and effective treatment using prostaglandin E1. Intern Med. 1998;37:861–4.CrossRefPubMed
19.
go back to reference Mattheou-Vakali G, Ioannides D, Thomas T, Lazaridou E, Tsogas P, Minas A. Cyclosporine in scleredema. J Am Acad Dermatol. 1996;35:990–1.CrossRefPubMed Mattheou-Vakali G, Ioannides D, Thomas T, Lazaridou E, Tsogas P, Minas A. Cyclosporine in scleredema. J Am Acad Dermatol. 1996;35:990–1.CrossRefPubMed
20.
go back to reference Dogramaci AC, Inan MU, Atik E, Gokce C. Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J. 2012;29:218–21.CrossRefPubMedPubMedCentral Dogramaci AC, Inan MU, Atik E, Gokce C. Scleredema diabeticorum partially treated with low-dose methotrexate: a report of five cases. Balkan Med J. 2012;29:218–21.CrossRefPubMedPubMedCentral
21.
go back to reference Breuckmann F, Appelhans C, Harati A, Rotterdam S, Altmeyer P, Kreuter A. Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology. 2005;211:299–301.CrossRefPubMed Breuckmann F, Appelhans C, Harati A, Rotterdam S, Altmeyer P, Kreuter A. Failure of low-dose methotrexate in the treatment of scleredema diabeticorum in seven cases. Dermatology. 2005;211:299–301.CrossRefPubMed
22.
go back to reference Matsuura K, Umebayashi Y, Otsuka F. Computed tomography reveals thickened subcutaneous tissue in scleroedema. Br J Dermatol. 1997;137:1015–6.CrossRefPubMed Matsuura K, Umebayashi Y, Otsuka F. Computed tomography reveals thickened subcutaneous tissue in scleroedema. Br J Dermatol. 1997;137:1015–6.CrossRefPubMed
23.
go back to reference Cole GW, Handler SJ, Burnett K. The ultrasonic evaluation of skin thickness in scleredema. J Clin Ultrasound. 1981;9:501–3.CrossRefPubMed Cole GW, Handler SJ, Burnett K. The ultrasonic evaluation of skin thickness in scleredema. J Clin Ultrasound. 1981;9:501–3.CrossRefPubMed
24.
go back to reference Blaicher W, Prayer D, Bernaschek G. Magnetic resonance imaging and ultrasound in the assessment of the fetal central nervous system. J Perinat Med. 2003;31:459–68.CrossRefPubMed Blaicher W, Prayer D, Bernaschek G. Magnetic resonance imaging and ultrasound in the assessment of the fetal central nervous system. J Perinat Med. 2003;31:459–68.CrossRefPubMed
25.
go back to reference Kokpol C, Rajatanavin N, Rattanakemakorn P. Successful treatment of scleredema diabeticorum by combining local PUVA and colchicine: a case report. Case Rep Dermatol. 2012;4:265–8.CrossRefPubMedPubMedCentral Kokpol C, Rajatanavin N, Rattanakemakorn P. Successful treatment of scleredema diabeticorum by combining local PUVA and colchicine: a case report. Case Rep Dermatol. 2012;4:265–8.CrossRefPubMedPubMedCentral
26.
go back to reference Thumpimukvatana N, Wongpraparut C, Lim HW. Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J Dermatol. 2010;37:1036–9.CrossRefPubMed Thumpimukvatana N, Wongpraparut C, Lim HW. Scleredema diabeticorum successfully treated with ultraviolet A1 phototherapy. J Dermatol. 2010;37:1036–9.CrossRefPubMed
27.
go back to reference Alsaeedi SH, Lee P. Treatment of scleredema diabeticorum with tamoxifen. J Rheumatol. 2010;37:2636–7.CrossRefPubMed Alsaeedi SH, Lee P. Treatment of scleredema diabeticorum with tamoxifen. J Rheumatol. 2010;37:2636–7.CrossRefPubMed
Metadata
Title
Clinical, radiological, and histological characteristics of Chinese type 2 diabetic patients with diabetic scleredema: an observational study
Authors
Yingying Zhou
Chaoming Wu
Zhijuan Dai
Jian Jin
Yaoxin Zhu
Yanying Qian
Publication date
01-07-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0705-3

Other articles of this Issue 3/2019

International Journal of Diabetes in Developing Countries 3/2019 Go to the issue